Therapeutic Potential of Resveratrol in the Treatment of Glioma: Insights into its Regulatory Mechanisms

Author(s): Ehsan Dadgostar, Maryam Fallah, Fatemeh Izadfar, Reza Heidari-Soureshjani, Michael Aschner, Omid Reza Tamtaji*, Hamed Mirzaei*

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 21 , Issue 18 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Glioma is a prevalent primary tumor of the brain and spinal cord. Several biological pathways play an important role in the pathogenesis of glioma, including apoptosis, autophagy, cell cycle arrest, migration, and invasion. The low efficacy of chemotherapy and radiation therapy has forced researchers to evaluate alternative treatments for glioma. In this regard, flavonoids have been studied. Resveratrol is a flavonoid with distinct pharmacological activities that has been used in the treatment of various diseases. Several recent studies have also focused on its therapeutic efficacy against glioma. Resveratrol exerts its pharmacological attributes by regulating various molecular and cellular pathways. Here, we review contemporary knowledge in support of the use of resveratrol in the treatment of glioma and its effects on various molecular and cellular mechanisms.

Keywords: Resveratrol, glioma, apoptosis, autophagy, metastasis, cell cycle arrest.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 06 April, 2021
Page: [2835 - 2847]
Pages: 13
DOI: 10.2174/1389557521666210406164758
Price: $65

Article Metrics

PDF: 272